These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 28161460)

  • 21. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.
    Manabe YC; Worodria W; van Leth F; Mayanja-Kizza H; Traore AN; Ferro J; Pakker N; Frank M; Grobusch MP; Colebunders R; Cobelens F
    Am J Trop Med Hyg; 2016 Dec; 95(6):1265-1271. PubMed ID: 27928077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of HIV and tuberculosis in the community.
    Frasca K; Cohn J
    J Int Assoc Provid AIDS Care; 2014; 13(6):534-8. PubMed ID: 25513636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated therapy for HIV and tuberculosis.
    Manosuthi W; Wiboonchutikul S; Sungkanuparph S
    AIDS Res Ther; 2016; 13():22. PubMed ID: 27182275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    Carlucci JG; Blevins Peratikos M; Kipp AM; Lindegren ML; Du QT; Renner L; Reubenson G; Ssali J; Yotebieng M; Mandalakas AM; Davies MA; Ballif M; Fenner L; Pettit AC;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):156-163. PubMed ID: 28234689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review.
    Momo Kadia B; Takah NF; Akem Dimala C; Smith A
    BMJ Open; 2019 Oct; 9(10):e031789. PubMed ID: 31662398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and mortality associated factors in patients infected with HIV receiving a presumptive anti-tuberculosis treatment in a tertiary level hospital in Burkina Faso.
    Diendéré EA; Badoum G; Bognounou R; Guira O; Ilboudo L; Tieno H; Diallo I; Drabo J
    AIDS Care; 2015; 27(10):1250-4. PubMed ID: 26291389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.
    Manosuthi W; Chottanapand S; Thongyen S; Chaovavanich A; Sungkanuparph S
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):42-6. PubMed ID: 16885778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
    Kerschberger B; Hilderbrand K; Boulle AM; Coetzee D; Goemaere E; De Azevedo V; Van Cutsem G
    PLoS One; 2012; 7(10):e46988. PubMed ID: 23071690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.
    Miyano S; Muvuma S; Ishikawa N; Endo H; Msiska C; Syakantu G
    BMC Health Serv Res; 2013 Oct; 13():397. PubMed ID: 24103082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study.
    Peck RN; Luhanga A; Kalluvya S; Todd J; Lugoba S; Fitzgerald DW; Downs JA
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1047-51. PubMed ID: 22691942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    Onyango DO; Yuen CM; Cain KP; Ngari F; Masini EO; Borgdorff MW
    PLoS One; 2017; 12(11):e0188235. PubMed ID: 29145454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis.
    Kay A; Mendez-Reyes J; Devezin T; Bakaya M; Steffy T; Dlamini S; Msekandiana A; Ness T; Bacha J; Amuge P; Matshaba M; Chodota M; Nyasulu P; Thahane L; Mwita L; Kekitiinwa A; DiNardo A; Lukhele B; Kirchner HL; Mandalakas A
    Clin Infect Dis; 2023 Jan; 76(1):10-17. PubMed ID: 36097966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
    Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
    Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study.
    Gray DM; Workman LJ; Lombard CJ; Jennings T; Innes S; Grobbelaar CJ; Cotton MF; Zar HJ
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):322-7. PubMed ID: 24670570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.